The Iliac/SFA/Popliteal Center

Filter Your Results




Data From Early Feasibility PREVEIL Study Presented for Surmodics SurVeil DCB

September 13, 2017 -- Surmodics, Inc. announced that data from the PREVEIL early feasibility study of the company’s SurVeil drug-coated balloon (DCB) were reported by Ga…

PQ Bypass Reports Data on the Detour System for Percutaneous Treatment of Long-Segment Femoropopliteal Artery Disease

September 12, 2017 -- PQ Bypass announced that a subset analysis from the DETOUR I clinical trial investigated the safety and effectiveness results of the company's Detour…

Data Presented for Medtronic's In.Pact Admiral DCB

September 12, 2017 -- Medtronic announced that the 2-year, real-world results from the full clinical cohort of the IN.PACT Global study and 4-year results from the pivotal IN.…

Medtronic's In.Pact Admiral DCB Approved in Japan

September 8, 2017 -- Medtronic announced that its In.Pact Admiral drug-coated balloon (DCB) received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) f…

B. Braun's Multi-Loc Multiple Stent Delivery System Evaluated to Treat Femoropopliteal Lesions

September 6, 2017 -- A report of 6-month outcomes from the first clinical experience with the Multi-Loc multiple stent delivery system (B. Braun Melsungen AG) for focal stenti…

Scoring System Proposed to Classify Patterns of Restenosis After Femoropopliteal Interventions

September 6, 2017 -- A proposed scoring system for the angiographic classification of patterns of restenosis after femoropopliteal artery intervention was published by Lawrenc…

FDA Approves Indication for Bard's Lutonix 035 DCB to Treat Dysfunctional AV Fistulas

August 28, 2017 -- Bard Peripheral Vascular, Inc. announced that the US Food and Drug Administration (FDA) has approved a new indication for the Lutonix 035 drug-coated balloo…

Getinge Announces Full Availability of Biotronik's Pulsar-18 Self-Expanding Stent in the United States

August 22, 2017 -- Getinge, which distributes Biotronik's portfolio of products to treat peripheral artery disease in the United States, announced the full United States m…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.